Prevalence and Correlates of Unhealthy Alcohol and Drug Use Among Men Who Have Sex with Men Prescribed HIV Pre-exposure Prophylaxis in Real-World Clinical Settings.


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 27 8 2018
medline: 19 3 2019
entrez: 27 8 2018
Statut: ppublish

Résumé

Pre-exposure prophylaxis (PrEP) is effective in preventing HIV acquisition among men who have sex with men (MSM). However, little is known about unhealthy substance use among MSM initiating PrEP in real-world settings. Unhealthy substance use is a risk factor for HIV acquisition and non-adherence to treatment, and may also impact PrEP use. MSM who were prescribed PrEP from 2015 to 2017 at clinics in Providence, Rhode Island and New Haven, Connecticut were recruited to participate in a prospective observational study. Structured clinical assessments were used to assess demographics, HIV risk behaviors, and unhealthy alcohol (alcohol use disorders identification test [AUDIT]-C scores ≥ 4) and drug use (use of any drugs in the past 3 months). Bivariate and multivariate analyses were performed to determine demographics and behaviors associated with unhealthy alcohol and drug use. Among 172 MSM initiating PrEP, 64% were white and 40% were 25-34 years old. Participants reported a median of 3 (IQR 2-7) sexual partners in the last 3 months; 20% reported an HIV positive partner. Unhealthy alcohol and any drug use were reported by 54 and 57%, respectively, and 76% reported at least one of the two. The majority of drug use reported was marijuana and poppers (41 and 26% of participants, respectively). Relative to those without unhealthy alcohol use, unhealthy alcohol use was independently associated with any drug use (adjusted odds ratio [AOR] = 2.57, 95% CI 1.32-5.01). Frequent drug use was associated with younger age (< 25 years, AOR 4.27, 95% CI 1.51-12.09). Unhealthy alcohol use is common among MSM taking PrEP. Drug use other than marijuana and poppers was uncommon among our cohort. Further efforts may be needed to understand the influence of unhealthy alcohol and other substance use on PrEP outcomes and to engage MSM who use drugs for PrEP.

Identifiants

pubmed: 30145707
doi: 10.1007/s10461-018-2260-9
pii: 10.1007/s10461-018-2260-9
pmc: PMC7020905
mid: NIHMS1555578
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

190-200

Subventions

Organisme : National Institutes of Health (US)
ID : K12DA033312
Organisme : NIMH NIH HHS
ID : R21 MH113431
Pays : United States
Organisme : NIH HHS
ID : R34MH110369
Pays : United States
Organisme : Yale Center for Interdisciplinary research on AIDS
ID : 5P30MH62294
Organisme : NIH HHS
ID : R34MH109371
Pays : United States
Organisme : NIDA NIH HHS
ID : K12 DA033312
Pays : United States
Organisme : Lifespan/Tufts/Brown Center for AIDS Research
ID : P30AI042853
Organisme : NIMH NIH HHS
ID : R21 MH109360
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI042853
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH109371
Pays : United States
Organisme : NIH HHS
ID : R21MH109360
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH114657
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH083620
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH062294
Pays : United States
Organisme : NIH HHS
ID : R34DA042648
Pays : United States
Organisme : NIDA NIH HHS
ID : R34 DA042648
Pays : United States
Organisme : NIH HHS
ID : R21MH113431
Pays : United States
Organisme : NICHD NIH HHS
ID : R25 HD045810
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH110369
Pays : United States

Références

Int J Drug Policy. 2017 May;43:33-43
pubmed: 28189979
AIDS Educ Prev. 2016 Oct;28(5):417-425
pubmed: 27710083
AIDS Behav. 2016 Mar;20(3):600-7
pubmed: 26400079
Drug Alcohol Depend. 2015 Feb 1;147:46-52
pubmed: 25555622
J Stud Alcohol. 1999 Jan;60(1):70-7
pubmed: 10096311
Lancet Infect Dis. 2014 Sep;14(9):820-9
pubmed: 25065857
Arch Intern Med. 2010 Jul 12;170(13):1155-60
pubmed: 20625025
AIDS Behav. 2014 Sep;18(9):1694-700
pubmed: 24752703
AIDS Patient Care STDS. 2016 May;30(5):221-8
pubmed: 27158850
Biomed Res Int. 2015;2015:850132
pubmed: 26779538
N Engl J Med. 2015 Feb 5;372(6):509-18
pubmed: 25651245
PLoS Clin Trials. 2007 May 25;2(5):e27
pubmed: 17525796
MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1291-5
pubmed: 26606148
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
AIDS Behav. 2015 Mar;19(3):422-30
pubmed: 25194967
Alcohol Clin Exp Res. 2007 Jul;31(7):1208-17
pubmed: 17451397
J Int AIDS Soc. 2018 Mar;21(3):e25103
pubmed: 29577616
N Engl J Med. 2012 Aug 2;367(5):411-22
pubmed: 22784040
N Engl J Med. 2010 Dec 30;363(27):2587-99
pubmed: 21091279
LGBT Health. 2014 Dec;1(4):319-22
pubmed: 26789859
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Drug Alcohol Depend. 2017 Jul 1;176:176-180
pubmed: 28549302
Alcohol Clin Exp Res. 2016 Oct;40(10):2056-2072
pubmed: 27696523
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):540-546
pubmed: 27851714
J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):171-8
pubmed: 22820808
Int J STD AIDS. 2018 Mar;29(3):244-250
pubmed: 28764613
J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S48-53
pubmed: 17133204
Sex Transm Dis. 2016 Nov;43(11):717-723
pubmed: 27893604
AIDS Behav. 2014 Jul;18(7):1330-8
pubmed: 24458782
Int J Public Health. 2010 Jun;55(3):159-66
pubmed: 19949966
Addiction. 2001 Nov;96(11):1589-601
pubmed: 11784456
AIDS Behav. 2017 Apr;21(4):1025-1033
pubmed: 27896552
Subst Abuse Treat Prev Policy. 2015 Jan 08;10:1
pubmed: 25575428
J Stud Alcohol Drugs. 2012 Nov;73(6):899-910
pubmed: 23036207
Lancet. 2016 Jan 2;387(10013):53-60
pubmed: 26364263
J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):419-425
pubmed: 27243904
N Engl J Med. 2005 Feb 10;352(6):596-607
pubmed: 15703424
Lancet. 2013 Jun 15;381(9883):2083-90
pubmed: 23769234
N Engl J Med. 2015 Dec 3;373(23):2237-46
pubmed: 26624850
AIDS Behav. 2010 Aug;14(4):731-47
pubmed: 19020970
J Urban Health. 2017 Oct;94(5):710-715
pubmed: 28600749
AIDS Care. 2013;25(7):888-94
pubmed: 23230862

Auteurs

Onyema Ogbuagu (O)

Yale AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA. Onyema.ogbuagu@yale.edu.

Brandon D L Marshall (BDL)

Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA.

Perry Tiberio (P)

Department of Medicine, Yale-New Haven Hospital, New Haven, CT, USA.

Adedotun Ogunbajo (A)

Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA.

Lydia Barakat (L)

Yale AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.

Madeline Montgomery (M)

Department of Medicine, Brown University, Providence, RI, USA.

Alexi Almonte (A)

Department of Medicine, Brown University, Providence, RI, USA.

Tyler Wray (T)

Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA.

Emily C Williams (EC)

Department of Health Services, University of Washington School of Public Health, Seattle, WA, USA.
Health Services Research & Development Center of Innovation for Veteran Centered and Value-Driven Care, VA Puget Sound, Seattle, WA, USA.

E Jennifer Edelman (EJ)

Section of General Internal Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT, USA.
Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA.

Philip A Chan (PA)

Department of Medicine, Brown University, Providence, RI, USA.
Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH